80 related articles for article (PubMed ID: 17455248)
1. Syndecan-1, a key regulator of cell viability in endometrial cancer.
Choi DS; Kim JH; Ryu HS; Kim HC; Han JH; Lee JS; Min CK
Int J Cancer; 2007 Aug; 121(4):741-50. PubMed ID: 17455248
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
Oh JH; Kim JH; Ahn HJ; Yoon JH; Yoo SC; Choi DS; Lee IS; Ryu HS; Min CK
Gynecol Oncol; 2009 Sep; 114(3):509-15. PubMed ID: 19539355
[TBL] [Abstract][Full Text] [Related]
3. [Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
Xiao L; Yang YB; Shen HM; Xu CF; Wang XY; Li XM
Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):681-5. PubMed ID: 20079181
[TBL] [Abstract][Full Text] [Related]
4. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
Gagnon V; St-Germain ME; Parent S; Asselin E
Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.
McCampbell AS; Broaddus RR; Loose DS; Davies PJ
Clin Cancer Res; 2006 Nov; 12(21):6373-8. PubMed ID: 17085648
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
7. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
8. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
[TBL] [Abstract][Full Text] [Related]
9. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
10. Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells.
Zhao LJ; Liu N; Li XP; Wang JL; Wei LH
Chin Med J (Engl); 2010 May; 123(9):1170-5. PubMed ID: 20529558
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors modulate proliferation and angiogenesis in human endometrial carcinoma.
Nickkho-Amiry M; McVey R; Holland C
Mol Cancer Res; 2012 Mar; 10(3):441-53. PubMed ID: 22205725
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent.
Guzeloglu Kayisli O; Kayisli UA; Luleci G; Arici A
Biol Reprod; 2004 Sep; 71(3):714-21. PubMed ID: 15115729
[TBL] [Abstract][Full Text] [Related]
13. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells.
Lilja JF; Wu D; Reynolds RK; Lin J
Anticancer Res; 2001; 21(3B):1969-74. PubMed ID: 11497285
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 overexpression promotes tumor growth and angiogenesis in an endometrial cancer xenograft model.
Oh JH; Lee HS; Park SH; Ryu HS; Min CK
Int J Gynecol Cancer; 2010 Jul; 20(5):751-6. PubMed ID: 20973264
[TBL] [Abstract][Full Text] [Related]
16. CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.
Pallares J; Llobet D; Santacana M; Eritja N; Velasco A; Cuevas D; Lopez S; Palomar-Asenjo V; Yeramian A; Dolcet X; Matias-Guiu X
Am J Pathol; 2009 Jan; 174(1):287-96. PubMed ID: 19056846
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Akt expression and phosphorylation by 17beta-estradiol in the rat uterus during estrous cycle.
Dery MC; Leblanc V; Shooner C; Asselin E
Reprod Biol Endocrinol; 2003 Jun; 1():47. PubMed ID: 12816542
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma.
Qiao Q; Li H
Biochem Biophys Res Commun; 2016 Sep; 478(2):507-12. PubMed ID: 27381864
[TBL] [Abstract][Full Text] [Related]
19. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
20. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.
Ogawa K; Sun C; Horii A
Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
